CHAPTER 26 Diuretic Drugs Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Diuretic Drugs Drugs that accelerate the rate of urine formation Results in the removal of sodium and water Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Sodium In the nephron, where sodium goes, water follows 20% to 25% of all sodium is reabsorbed into the bloodstream in the ascending loop of Henle 5% to 10% is reabsorbed in the distal convoluted tubules 3% is reabsorbed in collecting ducts If water is not absorbed, it is excreted as urine Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 3 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 4 Types of Diuretic Drugs Carbonic anhydrase inhibitors Loop diuretics Osmotic diuretics Potassium-sparing diuretics Thiazide and thiazide-like diuretics Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 5 Carbonic Anhydrase Inhibitors (CAIs) acetazolamide (Diamox) methazolamide (Neptazane) Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 6 Carbonic Anhydrase Inhibitors: Mechanism of Action The enzyme carbonic anhydrase helps to make H+ ions available for exchange with sodium and water in the proximal tubules CAIs block the action of carbonic anhydrase, thus preventing the exchange of H+ ions with sodium and water Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 7 Carbonic Anhydrase Inhibitors: Mechanism of Action (cont’d) Inhibition of carbonic anhydrase reduces H+ ion concentration in renal tubules As a result, there is increased excretion of bicarbonate, sodium, water, and potassium Resorption of water is decreased, and urine volume is increased Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 8 Carbonic Anhydrase Inhibitors: Indications Adjunct drugs in the long-term management of open-angle glaucoma Used with miotics to lower intraocular pressure before ocular surgery in certain cases Also useful in the treatment of: Edema Epilepsy High-altitude sickness Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 9 Carbonic Anhydrase Inhibitors: Indications (cont’d) Acetazolamide is used in the management of edema secondary to HF when other diuretics are not effective CAIs are less potent diuretics than loop diuretics or thiazides—the metabolic acidosis they induce reduces their diuretic effect in 2 to 4 days Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 10 Carbonic Anhydrase Inhibitors: Adverse Effects Metabolic acidosis Anorexia Hematuria Photosensitivity Melena Hypokalemia Drowsiness Paresthesias Urticaria Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 11 Loop Diuretics bumetanide (Bumex) furosemide (Lasix) torsemide (Demedex) Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 12 Loop Diuretics: Mechanism of Action Act directly on the ascending limb of the loop of Henle to inhibit chloride and sodium resorption Increase renal prostaglandins, resulting in the dilation of blood vessels and reduced peripheral vascular resistance Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 13 Loop Diuretics: Drug Effects Potent diuresis and subsequent loss of fluid Decreased fluid volume causes a reduction in: BP Pulmonary vascular resistance Systemic vascular resistance Central venous pressure Left ventricular end-diastolic pressure Potassium and sodium depletion Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 14 Loop Diuretics: Indications Edema associated with HF or hepatic or renal disease To control hypertension To increase renal excretion of calcium in patients with hypercalcemia In cases of HF resulting from diastolic dysfunction Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 15 Loop Diuretics: Adverse Effects Body System CNS Adverse Effects Dizziness, headache, tinnitus, blurred vision GI Nausea, vomiting, diarrhea Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 16 Loop Diuretics: Adverse Effects (cont’d) Body System Hematologic Adverse Effects Agranulocytosis, neutropenia, thrombocytopenia Metabolic Hypokalemia, hyperglycemia, hyperuricemia Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 17 Osmotic Diuretics mannitol (Osmitrol) Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 18 Osmotic Diuretics: Mechanism of Action Work mostly in the proximal tubule Nonabsorbable, producing an osmotic effect Pull water into the renal tubules from the surrounding tissues Inhibit tubular resorption of water and solutes, thus producing rapid diuresis Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 19 Osmotic Diuretics: Drug Effects Increases glomerular filtration rate and renal plasma flow—helps to prevent kidney damage during acute renal failure Reduces excessive intraocular pressure Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 20 Osmotic Diuretics: Indications Treatment of patients in the early, oliguric phase of ARF To promote excretion of toxic substances To reduce intracranial pressure Treatment of cerebral edema NOT indicated for peripheral edema Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 21 Osmotic Diuretics: Adverse Effects Convulsions Thrombophlebitis Pulmonary congestion Also headaches, chest pains, tachycardia, blurred vision, chills, and fever Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 22 Osmotic Diuretics: Mannitol Intravenous infusion only May crystallize when exposed to low temperatures—use of a filter is required Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 23 Potassium-Sparing Diuretics amiloride (Midamor) spironolactone (Aldactone) triamterene (Dyrenium) Also known as aldosterone-inhibiting diuretics Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 24 Potassium-Sparing Diuretics: Mechanism of Action Work in collecting ducts and distal convoluted tubules Interfere with sodium-potassium exchange Competitively bind to aldosterone receptors Block resorption of sodium and water usually induced by aldosterone Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 25 Potassium-Sparing Diuretics: Drug Effects Prevent potassium from being pumped into the tubule, thus preventing its secretion Competitively block aldosterone receptors and inhibit their action Promote the excretion of sodium and water Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 26 Potassium-Sparing Diuretics: Indications spironolactone and triamterene Hyperaldosteronism Hypertension Reversing potassium loss caused by potassium-losing drugs Certain cases of HF amiloride Treatment of HF Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 27 Potassium-Sparing Diuretics: Adverse Effects Body System Adverse Effects CNS Dizziness, headache GI Cramps, nausea, vomiting, diarrhea Other Urinary frequency, weakness, hyperkalemia Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 28 Potassium-Sparing Diuretics: Adverse Effects (cont’d) spironolactone Gynecomastia Amenorrhea Irregular menses Postmenopausal bleeding Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 29 Thiazide and Thiazide-like Diuretics Thiazide diuretics hydrochlorothiazide (Esidrix, HydroDIURIL) chlorothiazide (Diuril) trichlormethiazide (Metahydrin) Thiazide-like diuretics metolazone (Mykrox, Zaroxolyn) Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 30 Thiazide and Thiazide-like Diuretics: Mechanism of Action Inhibit tubular resorption of sodium, chloride, and potassium ions Action primarily in the distal convoluted tubule Result: water, sodium, and chloride are excreted Potassium is also excreted to a lesser extent Dilate the arterioles by direct relaxation Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 31 Thiazide and Thiazide-like Diuretics: Drug Effects Lowered peripheral vascular resistance Depletion of sodium and water (and potassium) Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 32 Thiazide and Thiazide-like Diuretics (cont’d) Thiazides should not be used if creatinine clearance is less than 30 to 50 mL/min (normal is 125 mL/min) Metolazone remains effective to a creatinine clearance of 10 mL/min Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 33 Thiazide and Thiazide-like Diuretics: Indications Hypertension (one of the most prescribed group of drugs for this) Edematous states Idiopathic hypercalciuria Diabetes insipidus Heart failure due to diastolic dysfunction Adjunct drugs in treatment of edema related to HF, hepatic cirrhosis, or corticosteroid or estrogen therapy Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 34 Thiazide and Thiazide-like Diuretics: Adverse Effects Body System CNS Adverse Effects Dizziness, headache, blurred vision, paresthesias, decreased libido GI Anorexia, nausea, vomiting, diarrhea Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 35 Thiazide and Thiazide-like Diuretics: Adverse Effects (cont’d) Body System GU Integumentary Metabolic Adverse Effects Impotence Urticaria, photosensitivity Hypokalemia, glycosuria, hyperglycemia hyperuricemia Others Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 36 Nursing Implications Perform a thorough patient history and physical examination Assess baseline fluid volume status, intake and output, serum electrolyte values, weight, and vital signs—especially postural BPs Assess for disorders that may contraindicate or necessitate cautious use of these drugs Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 37 Nursing Implications (cont’d) Instruct patients to take the medication in the morning if possible to avoid interference with sleep patterns Monitor serum potassium levels during therapy Potassium supplements are usually not recommended when potassium levels exceed 3 mEq/L Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 38 Nursing Implications (cont’d) Teach patients to maintain proper nutritional and fluid volume status Teach patients to eat more potassium-rich foods when taking any but the potassiumsparing drugs Foods high in potassium include bananas, oranges, dates, apricots, raisins, broccoli, green beans, potatoes, meats, fish, and legumes Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 39 Nursing Implications (cont’d) Patients taking diuretics along with a digitalis preparation should be taught to monitor for digitalis toxicity Diabetic patients who are taking thiazide and/or loop diuretics should be told to monitor blood glucose and watch for elevated levels Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 40 Nursing Implications (cont’d) Teach patients to change positions slowly and to rise slowly after sitting or lying to prevent dizziness and fainting related to orthostatic hypotension Encourage patients to keep a log of their daily weight Remind patients to return for follow-up visits and labwork Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 41 Nursing Implications (cont’d) Patients who have been ill with nausea, vomiting, and/or diarrhea should notify their physician because fluid loss may be dangerous Signs and symptoms of hypokalemia include muscle weakness, constipation, irregular pulse rate, and overall feeling of lethargy Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 42 Nursing Implications (cont’d) Instruct patients to notify their physician immediately if they experience rapid heart rates or syncope (reflects hypotension or fluid loss) A weight gain of 2 or more pounds a day or 5 or more pounds a week should be reported immediately Excessive consumption of licorice can lead to additive hypokalemia in patients taking thiazides Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 43 Nursing Implications (cont’d) Monitor for adverse effects: Metabolic alkalosis, drowsiness, lethargy, hypokalemia, tachycardia, hypotension, leg cramps, restlessness, decreased mental alertness Monitor for hyperkalemia with potassiumsparing diuretics Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 44 Nursing Implications (cont’d) Monitor for therapeutic effects Reduction of edema, fluid volume overload, HF Reduction of hypertension Return to normal intraocular pressures Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. 45